For the Quarter Ending December 2024
North America
In Q4 2024, Metoprolol Succinate prices in the USA experienced notable fluctuations, influenced by changing market dynamics. October saw a sharp price increase driven by rising demand, bolstered by Federal Reserve rate cuts that boosted consumer confidence. However, ongoing port congestion, labor strikes, and concerns over potential tariff hikes under President-elect Donald Trump disrupted supply chains, worsening the supply-demand imbalance and pushing prices higher.
By November, the market shifted as demand weakened under the pressure of inflation and high interest rates. The stronger U.S. dollar reduced import costs, and the resolution of the ILA strike helped ease logistical challenges. These factors, along with strong inventory levels, enabled suppliers to reduce prices, passing on savings to consumers.
In December, Metoprolol Succinate prices continued to decline, driven by lower consumer confidence, slower seasonal demand, and proactive inventory buildup in anticipation of January strikes and the Chinese Lunar New Year. Inflation concerns and tariff uncertainties led to more cautious purchasing, while ample supply and competitive pricing strategies exerted downward pressure. By the end of Q4, Metoprolol Succinate was priced at USD 50,250 per metric ton (USP, FDA) CFR Los Angeles, marking a decline from earlier in the quarter. Overall, Q4 was characterized by volatility, with the market ultimately trending downward.
Asia Pacific
In Q4 2024, the Metoprolol Succinate market in China experienced a dynamic pricing trend, shaped by a range of economic and market forces. In October, prices saw a notable increase, driven by the rebound of China's manufacturing sector, supported by government stimulus measures. Rising domestic and export demand, alongside monetary easing and a weaker yuan, boosted consumer confidence and external orders, allowing suppliers to raise prices.
However, by November, the upward trend reversed. High inventory levels, sluggish domestic demand, and weaker international orders—especially from the USA and Europe—resulted in an oversupply. The decline in crude oil prices further lowered operational costs, prompting manufacturers to reduce prices to stay competitive in a softer market.
In December, prices continued to decline due to weakened consumer demand amidst ongoing disinflation in China. Adjustments in procurement strategies by pharmaceutical companies and international buyers further contributed to the slowdown in demand. Reduced foreign orders during the holiday season led to excess inventory, pushing suppliers to cut prices in an effort to clear stock before year-end. Overall, Q4 saw a shift from October’s price increases to a downward trend in the following months, driven by fluctuating demand and evolving market conditions. By the end of Q4, Metoprolol Succinate was priced at USD 50,000 per metric ton FOB Shanghai in China.
Europe
In Q4 2024, Metoprolol Succinate prices in Germany exhibited fluctuating trends throughout the quarter. October saw a notable price increase, driven by improved business sentiment fueled by optimism about economic recovery and the European Central Bank’s third interest rate cut to 3.25%. This monetary easing encouraged spending and investment, while preemptive inventory buildup and ongoing supply chain challenges, such as delays at Hamburg’s ports, contributed to upward price pressure.
However, by November, the trend shifted. Weak demand from end-sectors and fading inflationary concerns led to a reduction in price pressures. A sharp decline in consumer spending and retail activity in Germany, coupled with a 1.9% drop in energy prices, lowered operational costs, enabling suppliers to offer more competitive prices.
The downward movement continued into December, driven by subdued demand from key sectors, cautious purchasing behavior amid lingering inflation concerns, and higher import costs due to the euro’s depreciation. Additionally, high inventories and year-end stock clearance efforts further pushed prices down, while harsh winter conditions disrupted consumer activity and logistics, exacerbating the decline. Overall, Q4 marked a shift from initial optimism to growing economic caution, which significantly impacted pricing. By the end of Q4, Metoprolol Succinate was priced at USD 50,150 per metric ton CFR Hamburg.
For the Quarter Ending September 2024
North America
In Q3 2024, the North American market for Metoprolol Succinate saw a notable increase in prices, driven by several key factors. A primary catalyst for this rise was the surge in demand for the medication, which was bolstered by an improved economic outlook and heightened consumer confidence. As consumers gained greater financial security, their willingness to purchase pharmaceuticals like Metoprolol Succinate increased, exerting upward pressure on prices.
However, this favorable demand was countered by supply chain challenges that limited product availability. Factors such as port congestion and adverse weather conditions disrupted the movement of goods, leading to supply constraints that further propelled price increases. Additionally, uncertainties related to the ongoing Red Sea crisis exacerbated shipping costs, prompting businesses to adopt more cautious procurement strategies. These external pressures compounded the already difficult supply environment.
By the conclusion of Q3 2024, the price of Metoprolol Succinate reached USD 58,800 per metric ton (USP, FDA) CFR Los Angeles. This price not only underscored a continued upward trend but also mirrored the prevailing positive sentiment in the market, shaped by the complex interaction between demand dynamics and supply-side constraints.
Asia Pacific
In the third quarter of 2024, Metoprolol Succinate prices in the APAC region exhibited a notable upward trajectory, influenced by several critical factors. A major driver of this price increase was strong global demand, especially from key markets, where foreign importers proactively secured sufficient supplies to guard against potential shortages. This heightened demand was further exacerbated by logistical challenges, such as disruptions in global shipping routes and escalating freight costs, which contributed to the overall price escalation. China became the epicenter of these developments, experiencing the most significant price fluctuations in the region. The country saw a notable rise in overseas demand coupled with a tightening supply scenario, leading to substantial price volatility. Overall, the quarter showcased a positive pricing landscape, marked by steady increases in prices throughout the period. By the conclusion of Q3 2024, Metoprolol Succinate was priced at USD 56,200 per metric ton (USP, FDA) FOB Shanghai. This final price reflects a robust and optimistic pricing sentiment over the quarter, emphasizing the persistent demand and supply pressures that have been shaping the market dynamics.
Europe
In Q3 2024, the European market for Metoprolol Succinate experienced a significant upward trend in pricing, influenced by several key factors. Strong demand from stable end-user needs provided a solid foundation for price increases. Simultaneously, a decrease in inflationary pressures across the region enhanced consumer purchasing power, further driving Metoprolol Succinate prices upward. The ongoing Red Sea crisis also played a crucial role, prompting retailers to proactively replenish their inventories in anticipation of potential disruptions during the critical Christmas trading season. This urgency, combined with disruptions in shipping lanes, sustained elevated demand and contributed to the overall price surge. Germany stood out as the region experiencing the most pronounced price fluctuations, mirroring the broader trends observed across Europe. Throughout the quarter, prices consistently trended upwards, with a 1% increase compared to the previous quarter. Seasonal patterns and correlations in price movements were evident, indicating synchronized growth in the market. Despite challenges such as fluctuating freight rates and logistical issues, the pricing environment remained predominantly favorable. By the end of the quarter, Metoprolol Succinate was priced at USD 57,950 per metric ton CFR Hamburg, underscoring the prevailing positive sentiment within the market.
For the Quarter Ending June 2024
North America
In Q2 2024, the pricing of Metoprolol Succinate in North America demonstrated a fluctuating pattern due to various market influences. The quarter opened with a decline in prices, experienced an uptick in the middle, and ended with another drop. Key factors in the USA, including consumer sentiment and economic indicators, were crucial in shaping demand and pricing trends.
In April, prices fell as domestic business activity slowed down, largely due to reduced new orders stemming from consumer hesitation amidst weak economic conditions. The Federal Reserve's decision to keep interest rates high to control inflation inadvertently weakened consumer purchasing power, reducing overall demand. However, prices began to rise mid-quarter, driven by a rebound in consumer demand. U.S. consumer confidence saw an unexpected boost in May, following three months of decline, supported by positive labor market expectations. Despite this short-lived optimism, prices declined again towards the end of the quarter. This was due to weaker-than-expected demand, evidenced by a notable drop in new orders and a shrinking order backlog. These trends, alongside diminishing new product orders and lower spending, signaled a gradual slowdown in economic activity.
Overall, while the quarter-on-quarter percentage change remained stable, there was a 2% increase in prices from the start to the end of the quarter. This stability reflects a sustained demand throughout the period. By the end of the quarter, the price for Metoprolol Succinate (USP, FDA) CFR Los Angeles in the USA was USD 57,700 per metric ton.
APAC
In Q2 2024, the Metoprolol Succinate market in the APAC region exhibited fluctuating pricing trends. The quarter began with a decrease in prices, saw an increase in the middle, and ended with another decline. China, experiencing the most significant price variations, mirrored the overall trends in the APAC region. In April, prices dropped due to several factors. There was subdued demand from end-user industries both domestically and abroad, which exerted downward pressure on prices. The market was also impacted by ample supply conditions, leading to oversupply and competitive price cuts as sellers sought to clear excess inventory. Compounding these issues were logistical disruptions and rising shipping costs, driven in part by geopolitical tensions, which further strained the supply chain and dampened buyer interest. However, prices rose in May as steady consumer demand and a constrained domestic supply created a more favorable environment for sellers. A decrease in China's factory activity indicator in May, attributed to reduced output, suggested a potential cutback in production capacity. This slowdown in manufacturing output further tightened supply, leading to a temporary increase in prices. Despite this short-lived improvement, prices fell again in June, reflecting a shift in market sentiment. In China, companies faced growing challenges, including declining consumer demand and increasing financial pressures, which contributed to the downward trend in Metoprolol Succinate prices.
Europe
In Q2 2024, the European Metoprolol Succinate market saw varying price trends influenced by complex supply-demand dynamics, consumer sentiment, and broader economic factors. At the beginning of the quarter, prices decreased due to weak market sentiment. This decline was driven by a sharp reduction in new orders and total sales volumes, which exerted significant downward pressure on prices. The situation was further exacerbated by inflationary pressures, particularly from high energy and food prices, which undermined consumer confidence and contributed to the price drop. However, in May, prices began to rise as demand from end-user industries, particularly pharmaceuticals, picked up. Market participants managed to keep inventories at appropriate levels, ensuring a stable supply chain and enabling quick responses to market changes. Despite this rebound, prices fell again in June due to a lack of genuine demand within the domestic market. Persistent concerns over inflation and high-interest rates led consumers to adopt a cautious spending approach, causing downstream sectors to be more reserved. The price trajectory from the previous quarter, which had seen a 2% decline, reversed sharply in Q2. By the end of the quarter, the price for Metoprolol Succinate was USD 56,800 per metric ton.
For the Quarter Ending March 2024
North America
In Q1 2024, the pricing dynamics of Metoprolol Succinate in the North America region, specifically in the USA, were influenced by a range of factors. The market situation in the USA played a significant role in shaping the pricing dynamics. The overall trend was characterized by an increase in prices in January, followed by decline in February and March 2024.
At the beginning of the quarter, prices for Metoprolol Succinate experienced a moderate increase, driven by heightened buying activity in downstream sectors, improved consumer confidence, and disruptions in transportation logistics. However, this upward trend was short-lived as consumer attitudes towards the economy grew increasingly cautious, reflecting a broader trend of uncertainty fueled by sluggish retail sales and subdued consumer spending. Persistent inflationary pressures further exacerbated this cautiousness, prompting consumers to adopt a more conservative approach to their finances. The Federal Reserve's obligation to implement higher interest rates to counteract inflationary pressures added to the financial strain experienced by consumers. Consequently, this has curbed their purchasing power, leading to a lower overall demand for Metoprolol Succinate in the USA market.
Despite the overall price increase in Q1 2024, there was a year-over-year decrease of 12% compared to the same quarter last year. The price at the end of the quarter was USD 57200/MT. It is important to note that the pricing dynamics in the Metoprolol Succinate market are influenced by a range of factors, and a nuanced analysis is necessary to understand the complex dynamics at play.
Asia Pacific
In Q1 2024, the pricing trends of Metoprolol Succinate in the APAC region were influenced by a variety of factors, reflecting a dynamic and volatile market environment. Notably, the market in China exhibited a mixed performance, with a significant year-over-year price increase of 29% compared to the same quarter last year, indicating heightened volatility compared to previous periods. The quarter began with a slight price increase in January, driven by improved manufacturing activities spurred by heightened demand across sectors such as healthcare and pharmaceuticals. Furthermore, expanding export orders indicated a slight uptick in overseas demand, contributing to the upward trajectory of prices. However, prices experienced a decline in February and March, attributed to reduced demand exacerbated by a global economic slowdown impacting Chinese exports. The closure of numerous companies during the Spring Festival in China also played a role in the decreased demand and oversupply in the market. Moreover, disruptions in the global supply chain caused by tensions in the Red Sea further affected exports from China, impacting pricing dynamics. The final quarter's price for Metoprolol Succinate (USP, FDA) FOB Shanghai in China was USD 56000/MT.
Europe
During Q1 2024, the pricing dynamics of Metoprolol Succinate in the Europe region were subject to a multitude of influences. At the onset of the quarter, prices experienced a slight increase amid a complex blend of geopolitical tensions, logistical challenges, and diminishing inventories. Despite these obstacles, downstream industries maintained a steady operational rhythm, fostering consistent demand for Metoprolol Succinate and consequently driving prices upwards. However, this upward trend was short-lived as prices began to decline thereafter, driven by a decrease in demand from various end-user industries. Additionally, there was a notable decrease in new orders, particularly within the domestic market, which further exacerbated the downward trajectory of prices. The market conditions in Germany were particularly unstable, characterized by economic challenges in the manufacturing sector and a decline in consumer sentiment. Furthermore, the decision of the central bank to maintain unchanged interest rates in March added to the burden on consumers. Also, the supply of Metoprolol Succinate remained adequate, with market participants actively clearing their existing stock at lower prices. In conclusion, the final quarter's price for Metoprolol Succinate (USP, FDA) CFR Hamburg in Germany stood at USD 56800 per metric ton.
